A Healthesystems publication

Fall 2015

Counteracting The Rise of Generic Pricing

Generics have long provided cost-effective, clinically appropriate alternatives to their more expensive brand-name counterparts. But steep increases to average wholesale prices (AWPs) for some generic medications are becoming a significant driver for rising claim costs, leaving payers to seek more aggressive strategies for cost containment.

To continue reading you must be logged in.

Please register for free or login to unlock the rest of this article.

RATE THIS ARTICLE

SOURCES

1 -Healthesystems data
2 -Department of Health and Human Services, Office of Inspector General. April 13, 2015. http://www.sanders.senate.gov/download/oig-letterto-sen-sanders-4-13-2015?inline=file. Accessed September 10, 2015.
3 -Elsevier data as reported in Forbes: Why Are Generic Drug Prices Shooting Up? February 2015. http://www.forbes.com/sites/greatspeculations/2015/02/27/why-are-genericdrug-prices-shooting-up/ Accessed September 10,2015.
Table of Contents